Walleye Capital LLC Theseus Pharmaceuticals, Inc. Transaction History

Walleye Capital LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$2.12 - $4.18 $22,145 - $43,664	-10,446 Reduced 32.65%	21,552 $87,000
Q3 2023 Nov 14, 2023	BUY	$2.66 - $10.04 $85,114 - $321,259	31,998 New	31,998 $86,000
Q1 2023 May 15, 2023	SELL	$5.21 - $14.05 $97,411 - $262,692	-18,697 Reduced 9.43%	179,550 $1.59 Million
Q4 2022 Feb 14, 2023	BUY	$4.69 - $8.36 $557,401 - $993,577	118,849 Added 149.69%	198,247 $987,000
Q3 2022 Nov 14, 2022	BUY	$5.7 - $8.68 $271,770 - $413,853	47,679 Added 150.32%	79,398 $461,000

Q2 2022 Aug 08, 2022	BUY	$5.04 - $14.05 $159,863 - $445,651	31,719 New	31,719 $175,000

1.06M

Ticker THRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,713,400
Description
Theseus Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of targeted therapies for the treatment of cancer patients. Its lead product candidate is THE-630, a pan-KIT inhibitor for the treatment of gastrointestinal stromal tumors, which is in Phase I clinical trial. The company also ...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.